Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.01), versus ($0.07) reported last year. Revenue for the quarter came in at $63.9 million, versus $59.7 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.